Press Releases Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 11:37:11 2026-05-14 am EDT			5-day change	1st Jan Change
38.18 ^EUR	+0.55%		+2.00%	+3.16%

May. 14	Bayer Kept at Buy as Mwb Notes 'Solid' Q1 Results	MT
May. 14	BAYER AG : JP Morgan maintains a Buy rating	ZD

Press Releases

May. 13	Bayer Partners with Luke Bryan to Donate 1 Million Meals Through Feeding America® to Expand Access to Food and Nutrition in Rural Communities	BU
May. 12	Bayer : Q1 Media Update	PU
May. 12	Bayer : First Quarter 2026 Results and Media Update	PU
May. 12	Bayer : Quarterly Statement First Quarter 2026	PU
May. 12	Bayer : reports solid start to the year and confirms currency-adjusted Group guidance for 2026	PU
May. 07	Bayer and bp Form Strategic Alliance to Jointly Scale Camelina as Intermediate Crop for Biofuels	AQ
May. 07	Bayer : China’s Center of Drug Evaluation grants Priority Review designation for Bayer’s FXIa inhibitor	PU
May. 07	Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis	BU
May. 06	Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline	BU
Apr. 30	Bayer - New study highlights societal optimism toward breakthrough science, and rising anxiety about how fast the world is changing	AQ
Apr. 29	New Study Highlights Societal Optimism Toward Breakthrough Science, and Rising Anxiety About How Fast the World Is Changing	BU
Apr. 29	Bayer to Present 13 Abstracts From Its Stroke Franchise at ESOC 2026, Including Two Late-breaking Analyses From the Phase III OCEANIC-STROKE Trial of Asundexian	BU
Apr. 29	Bayer : China’s Center of Drug Evaluation accepts marketing authorization application for asundexian in stroke prevention after a non-cardioembolic ischemic stroke or transient ischemic attack	PU
Apr. 29	Bayer : New study highlights societal optimism toward breakthrough science, and rising anxiety about how fast the world is changing	PU
Apr. 27	Bayer : Notice of Dividend 2026	PU
Apr. 25	Bayer : Results (voting results asm 2026)	PU
Apr. 24	Bayer : Results (voting results asm2026)	PU
Apr. 24	Bayer : Annual Stockholders' Meeting 2026	PU
Apr. 24	Bayer : Address by Bill Anderson	PU
Apr. 24	Bayer : Explanations relating to the Supervisory Board Report	PU
Apr. 24	Bayer : “We see great progress, but the work isn’t complete yet”	PU
Apr. 23	Bayer : Privacy Information for Attendees (privacy information for attendees asm2026)	PU
Apr. 20	Bayer : AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease	PU
Apr. 16	Bayer : Asundexian OCEANIC-STROKE Phase III study results demonstrating substantial reduction in ischemic stroke with no increase in ISTH major bleeding versus placebo published in New England Journal of Medicine	PU
Apr. 01	Bayer : strongest-ever pharma portfolio and promising pipeline drive future growth	PU